- Scope of the procurement
- Lot 8. Cancer Medicines (Group 2)
- Lot 1. Cytokine Modulators
- Lot 2. Gastrointestinal, Endocrine, Nutrition, Blood, and Multiple Sclerosis Medicines
- Lot 3. Denosumab (osteoporosis)
- Lot 4. Apremilast
- Lot 5. Cardiovascular and Respiratory Medicines
- Lot 6. Nintedanib
- Lot 7. Cancer Medicines (Group 1)
- Lot 9. Neurology Medicines
Section one: Contracting authority
one.1) Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
1 South Gyle Crescent
Edinburgh
EH12 9EB
Contact
Cameron Wright
Telephone
+44 1312756000
Country
United Kingdom
NUTS code
UKM - Scotland
Internet address(es)
Main address
http://www.nss.nhs.scot/browse/procurement-and-logistics
Buyer's address
https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
one.2) Information about joint procurement
The contract is awarded by a central purchasing body
one.3) Communication
Additional information can be obtained from the above-mentioned address
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NP49425 Generic and Biosimilar Transition Medicines
two.1.2) Main CPV code
- 33600000 - Pharmaceutical products
two.1.3) Type of contract
Supplies
two.1.4) Short description
The Authority seeks to establish a Framework Agreement covering medicines that are imminently approaching or have already reached Loss of Exclusivity (LoE).
The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape):
- Apremilast 30mg tablets
- Axitinib 1mg tablets
- Axitinib 3mg tablets
- Axitinib 5mg tablets
- Axitinib 7mg tablets
- Betaine oral powder
- Denosumab 120mg/1.7ml solution for injection vials
- Denosumab 120mg/1ml solution for injection pre-filled syringes
- Denosumab 60mg/1ml solution for injection pre-filled syringes
- Eltrombopag 25mg oral powder sachets sugar free
- Eltrombopag 25mg tablets
- Eltrombopag 50mg tablets
- Eltrombopag 75mg tablets
- Ferric carboxymaltose 100mg/2ml dispersion for injection vials
- Ferric carboxymaltose 1g/20ml dispersion for injection vials
- Ferric carboxymaltose 500mg/10ml dispersion for injection vials
- Fluticasone furoate 27.5micrograms/dose nasal spray
- Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray
- Generic Otezla tablets treatment initiation pack
- Generic Sustanon 250mg/1ml solution for injection ampoules
- Golimumab 100mg/1ml solution for injection pre-filled disposable devices
- Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices
- Golimumab 50mg/0.5ml solution for injection pre-filled syringes
- Lanreotide 120mg/0.5ml solution for injection pre-filled syringes
- Lanreotide 90mg/0.5ml solution for injection pre-filled syringes
- Lanreotide 60mg/0.5ml solution for injection pre-filled syringes
- Mesalazine 1.5g gastro-resistant modified-release granules sachets sugar free
- Mesalazine 1.6g gastro-resistant tablets
- Mesalazine 1g gastro-resistant modified-release granules sachets sugar free
- Mesalazine 1g modified-release granules sachets sugar free
- Mesalazine 1g modified-release tablets
- Mesalazine 1g suppositories
- Mesalazine 1g/100ml enema
- Mesalazine 1g/application foam enema
- Mesalazine 250mg gastro-resistant tablets
- Mesalazine 2g modified-release granules sachets sugar free
- Mesalazine 2g/59ml enema
- Mesalazine 400mg gastro-resistant tablets
- Mesalazine 4g modified-release granules sachets sugar free
- Mesalazine 500mg gastro-resistant modified-release granules sachets sugar free
- Mesalazine 500mg gastro-resistant tablets
- Mesalazine 500mg suppositories
- Mesalazine 800mg gastro-resistant tablets
- Nilotinib 150mg capsules
- Nilotinib 200mg capsules
- Nilotinib 50mg capsules
- Nintedanib 100mg capsules
- Nintedanib 150mg capsules
- Omalizumab 150mg/1ml solution for injection pre-filled syringes
- Omalizumab 75mg/0.5ml solution for injection pre-filled syringes
- Omalizumab 300mg/2ml solution for injection pre-filled disposable devices
- Omalizumab 300mg/2ml solution for injection pre-filled syringes
- Pazopanib 200mg tablets
- Pazopanib 400mg tablets
- Perampanel 10mg tablets
- Perampanel 12mg tablets
- Perampanel 2mg tablets
- Perampanel 4mg tablets
- Perampanel 500micrograms/ml oral suspension sugar free
- Perampanel 6mg tablets
- Perampanel 8mg tablets
- Pertuzumab 420mg/14ml solution for infusion vials 1 vial
- Testosterone undecanoate 1g/4ml solution for injection ampoules
- Testosterone undecanoate 1g/4ml solution for injection vials
- Ticagrelor 60mg tablets
- Ticagrelor 90mg orodispersible tablets sugar free
- Ticagrelor 90mg tablets
- Tocilizumab 162mg/0.9ml solution for injection pre-filled disposable devices
- Tocilizumab 162mg/0.9ml solution for injection pre-filled syringes
- Tocilizumab 200mg/10ml solution for infusion vials
- Tocilizumab 400mg/20ml solution for infusion vials
- Tocilizumab 80mg/4ml solution for infusion vials
- Trabectedin 1mg powder for solution for infusion vials
- Trabectedin 250microgram powder for solution for infusion vials
two.1.5) Estimated total value
Value excluding VAT: £131,244,104
two.1.6) Information about lots
This contract is divided into lots: Yes
two.2) Description
two.2.1) Title
Cancer Medicines (Group 2)
Lot No
8
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of cancer medicines (Group 2) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Cytokine Modulators
Lot No
1
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of cytokine modulators to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Gastrointestinal, Endocrine, Nutrition, Blood, and Multiple Sclerosis Medicines
Lot No
2
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of gastrointestinal, endocrine, nutrition, blood, and multiple sclerosis medicines NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Denosumab (osteoporosis)
Lot No
3
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of denosumab (osteoporosis) to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Apremilast
Lot No
4
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of apremilast to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Cardiovascular and Respiratory Medicines
Lot No
5
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Nintedanib
Lot No
6
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of nintedanib to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Cancer Medicines (Group 1)
Lot No
7
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of cancer medicines (Group 1) to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.2) Description
two.2.1) Title
Neurology Medicines
Lot No
9
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of neurology medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line. Full details of Goods and volumes will be found within the ITT documents once published.
two.3) Estimated date of publication of contract notice
15 August 2025
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section six. Complementary information
six.3) Additional information
The estimated values referred to in Section II.1.5 cover maximum forty-eight (48) month duration of the Framework Agreement (comprised of the initial duration and any extension duration(s) combined).
NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=801883.
(SC Ref:801883)